Literature DB >> 22311128

Neuroinflammation and synaptic loss.

Jagadeesh S Rao1, Matthew Kellom, Hyung-Wook Kim, Stanley I Rapoport, Edmund A Reese.   

Abstract

Neuroinflammation plays a critical role in the progression of many neurodegenerative, neuropsychiatric and viral diseases. In neuroinflammation, activated microglia and astrocytes release cytokines and chemokines as well as nitric oxide, which in turn activate many signal transduction pathways. The cytokines, interleukin-1 beta and tumor necrosis factor alpha, regulate transcription of a number of genes within the brain, which can lead to the formation of pro-inflammatory products of the arachidonic acid cascade. Formation of pro-inflammatory agents and associated cytotoxic products during neuroinflammation can be detrimental to neurons by altering synaptic proteins. Neuroinflammation as well as excitotoxic insults reduce synaptic markers such as synaptophysin and drebrin. Neurodegenerative, neuropsychiatric illnesses and viral infections are accompanied by loss of both pre- and post-synaptic proteins. These synaptic changes may contribute to the progressive cognitive decline and behavioral changes associated with these illnesses.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22311128      PMCID: PMC3478877          DOI: 10.1007/s11064-012-0708-2

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  61 in total

1.  Overexpression of drebrin A in immature neurons induces the accumulation of F-actin and PSD-95 into dendritic filopodia, and the formation of large abnormal protrusions.

Authors:  Toshiyuki Mizui; Hideto Takahashi; Yuko Sekino; Tomoaki Shirao
Journal:  Mol Cell Neurosci       Date:  2005-09       Impact factor: 4.314

Review 2.  Can the immune system be harnessed to repair the CNS?

Authors:  Phillip G Popovich; Erin E Longbrake
Journal:  Nat Rev Neurosci       Date:  2008-06       Impact factor: 34.870

3.  Neuroinflammation in Alzheimer's disease and major depression.

Authors:  Nikoletta Dobos; Jakob Korf; Paul G M Luiten; Ulrich L M Eisel
Journal:  Biol Psychiatry       Date:  2010-03-15       Impact factor: 13.382

Review 4.  Synaptic dysfunction and disruption of postsynaptic drebrin-actin complex: a study of neurological disorders accompanied by cognitive deficits.

Authors:  Nobuhiko Kojima; Tomoaki Shirao
Journal:  Neurosci Res       Date:  2007-02-11       Impact factor: 3.304

Review 5.  Phospholipase A2.

Authors:  Makoto Murakami; Ichiro Kudo
Journal:  J Biochem       Date:  2002-03       Impact factor: 3.387

6.  Neuroinflammation in schizophrenia-related psychosis: a PET study.

Authors:  Janine Doorduin; Erik F J de Vries; Antoon T M Willemsen; Jan Cees de Groot; Rudi A Dierckx; Hans C Klein
Journal:  J Nucl Med       Date:  2009-10-16       Impact factor: 10.057

7.  Distinct regulation of cytosolic phospholipase A2 phosphorylation, translocation, proteolysis and activation by tumour necrosis factor-receptor subtypes.

Authors:  Orla J Jupp; Peter Vandenabeele; David J MacEwan
Journal:  Biochem J       Date:  2003-09-01       Impact factor: 3.857

Review 8.  Neurocognitive impairment in bipolar disorder patients: functional implications.

Authors:  Aliza P Wingo; Philip D Harvey; Ross J Baldessarini
Journal:  Bipolar Disord       Date:  2009-03       Impact factor: 6.744

Review 9.  Mediation of inflammation by cyclooxygenase-2.

Authors:  K Seibert; J Masferrer; Y Zhang; S Gregory; G Olson; S Hauser; K Leahy; W Perkins; P Isakson
Journal:  Agents Actions Suppl       Date:  1995

10.  Cognitive impairment of executive function as a core symptom of schizophrenia.

Authors:  Thomas Wobrock; Ullrich K H Ecker; Harald Scherk; Thomas Schneider-Axmann; Peter Falkai; Oliver Gruber
Journal:  World J Biol Psychiatry       Date:  2009       Impact factor: 4.132

View more
  75 in total

1.  Lipolysaccharide-Induced Neuroinflammation Is Associated with Alzheimer-Like Amyloidogenic Axonal Pathology and Dendritic Degeneration in Rats.

Authors:  Xiaohua Deng; Meili Li; Weiming Ai; Lixin He; Dahua Lu; Peter R Patrylo; Huaibin Cai; Xuegang Luo; Zhiyuan Li; Xiaoxin Yan
Journal:  Adv Alzheimer Dis       Date:  2014-06

2.  Acute brain inflammation and oxidative damage are related to long-term cognitive deficits and markers of neurodegeneration in sepsis-survivor rats.

Authors:  Mágada T Schwalm; Matheus Pasquali; Samantha P Miguel; João Paulo A Dos Santos; Francieli Vuolo; Clarissa M Comim; Fabrícia Petronilho; João Quevedo; Daniel P Gelain; José Cláudio F Moreira; Cristiane Ritter; Felipe Dal-Pizzol
Journal:  Mol Neurobiol       Date:  2013-08-30       Impact factor: 5.590

Review 3.  [Research progress of depression and the application of esketamine].

Authors:  Fang-Bo Lin; De-Ren Hou; Qiu-Ping Tang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2016-04-20

Review 4.  Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target?

Authors:  Robert K McNamara; Francis E Lotrich
Journal:  Expert Rev Neurother       Date:  2012-09       Impact factor: 4.618

5.  Valnoctamide, a non-teratogenic amide derivative of valproic acid, inhibits arachidonic acid activation in vitro by recombinant acyl-CoA synthetase-4.

Authors:  Hiren R Modi; Mireille Basselin; Stanley I Rapoport
Journal:  Bipolar Disord       Date:  2014-07-08       Impact factor: 6.744

6.  'Neuroinflammation' differs categorically from inflammation: transcriptomes of Alzheimer's disease, Parkinson's disease, schizophrenia and inflammatory diseases compared.

Authors:  Michaela D Filiou; Ahmed Shamsul Arefin; Pablo Moscato; Manuel B Graeber
Journal:  Neurogenetics       Date:  2014-06-15       Impact factor: 2.660

7.  Association of the CX3CR1-V249I Variant with Neurofibrillary Pathology Progression in Late-Onset Alzheimer's Disease.

Authors:  Alan López-López; Ellen Gelpi; Diana Maria Lopategui; Jose M Vidal-Taboada
Journal:  Mol Neurobiol       Date:  2017-03-25       Impact factor: 5.590

Review 8.  Targeting Tumor Necrosis Factor Alpha for Alzheimer's Disease.

Authors:  Boris Decourt; Debomoy K Lahiri; Marwan N Sabbagh
Journal:  Curr Alzheimer Res       Date:  2017       Impact factor: 3.498

9.  Yin Yang 1 is a repressor of glutamate transporter EAAT2, and it mediates manganese-induced decrease of EAAT2 expression in astrocytes.

Authors:  Pratap Karki; Anton Webb; Keisha Smith; James Johnson; Kyuwon Lee; Deok-Soo Son; Michael Aschner; Eunsook Lee
Journal:  Mol Cell Biol       Date:  2014-01-27       Impact factor: 4.272

10.  Effects of triptolide on degeneration of dendritic spines induced by Aβ1-40 injection in rat hippocampus.

Authors:  Bin Wan; Xiaoling Hu; Jing Nie; Ming Zhou; Baolin Yang; Yaobing Li; Wei Wen; Cheng Lü
Journal:  Neurol Sci       Date:  2013-05-29       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.